Koyfin Home > Directory > Health Care > Aeglea Biothera > EV / EBITDA (ltm)

Aeglea Biothera EV / EBITDA (ltm) Chart (AGLE)

Aeglea Biothera annual/quarterly EV / EBITDA (ltm) from 2016 to 2017. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Aeglea Biothera EV / EBITDA (ltm) for the quarter ending August 08, 2017 was 0.09 a -457.72% decrease of -0.41 year over year
  • Aeglea Biothera EV / EBITDA (ltm) for the last 12 months ending August 08, 2017 was 0.09 a -457.72% decrease of -0.41 year over year
  • Aeglea Biothera Annual EV / EBITDA (ltm) for 2017 was 0.09 a -315.13% decrease of -0.28 from 2016
  • Aeglea Biothera Annual EV / EBITDA (ltm) for 2017 was 0.37 a -3.62% decrease of -0.01 from 2016
  • Aeglea Biothera Annual EV / EBITDA (ltm) for 2017 was 0.38 a -29.66% decrease of -0.11 from 2016
Other Valuation Metrics:
  • Aeglea Biothera Market Cap for the quarter ending March 03, 2018 was $166m a 61.80% increase of 102m year over year
  • Aeglea Biothera Price / Book for the quarter ending March 03, 2018 was 3.29 a 72.43% increase of 2.38 year over year
  • Aeglea Biothera Enterprise Value for the quarter ending March 03, 2018 was $116m a 95.26% increase of 110m year over year
View Chart On Koyfin

Quarterly AGLE EV / EBITDA (ltm) Data

08/20170.09
08/20170.37
08/20170.38
08/20170.49
08/20170.53
08/20170.50
08/20170.56
08/20170.59
08/20170.63
08/20170.59

Annual AGLE EV / EBITDA (ltm) Data

20170.09
20170.37
20170.38
20170.49
20170.53
20170.50
20170.56
20170.59
20170.63
20170.59